Deep Labs conducted the project with the help of Visual Connections, a Windsor Mill, Md.-based firm providing IT and data analytics services to state and federal clients. Together, the companies developed an advanced AI system able to proactively identify potentially fraudulent activity in records from CMS’ Medicare Part D prescription drug benefit program.
The system was a “tremendous success,” able to review millions of records per second and mark any suspicious ones for further investigation, according to Frederick Deese, founder and CEO of Visual Connections. “We are extremely proud to have successfully flagged these potential losses for the CMS, as it strives to cut its waste and overall losses,” added Scott Edington, CEO of Deep Labs.
More articles on AI:
Viewpoint: AI is incompatible with the real-world practice of medicine
Mayo Clinic invests in breast cancer imaging AI
3 lessons NewYork-Presbyterian learned from using AI to reduce length of stay
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
